Physician profile
Jamison Engle
NPI 1578792446
$6,424.05
in general payments reported to CMS, 2019-2025
16 companies · $1,172 in 2025
The $1,172 reported for 2025 was more than what 81% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $645 · 2020: $444 · 2021: $469 · 2022: $1,017 · 2023: $1,428 · 2024: $1,249 · 2025: $1,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,823 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,822.84 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,481.21 | 2019-2025 | Clareon, Clareon Panoptix Pro, Argos |
| Rxsight INC | $1,147.71 | 2021-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Glaukos Corporation | $778.61 | 2019-2025 | Idose, Photrexa Viscous and Photrexa, Idosetr |
| Johnson & Johnson Surgical Vision, INC. | $283.04 | 2019-2022 | |
| Rayner Intraocular Lenses Limited | $224.23 | 2022-2024 | Omidria, Rayone Spheric, Rayone Emv |
| Biotissue Holdings INC. | $114.73 | 2024 | |
| Dompe US, INC. | $95.08 | 2019-2025 | Oxervate |
| Omeros Corporation | $74.33 | 2019-2021 | |
| Allergan, INC. | $68.14 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $37.51 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $35.89 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $20.52 | 2019 | |
| Oyster Point Pharma, INC. | $20.33 | 2022 | |
| Kala Pharmaceuticals, INC. | $16.16 | 2022 | |
| Sight Sciences, INC. | $14.01 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $12.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamison Engle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.